Bio-Techne

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$286,555
$316,964
$316,181
$297,031
Gross Profit
190,191
198,812
214,556
193,886
EBITDA
77,799
6,430
67,852
72,108
EBIT
53,459
-20,681
40,281
45,024
Net Income
38,179
-17,678
22,588
34,890
Net Change In Cash
286,555
316,964
316,181
297,031
Free Cash Flow
22,222
93,311
30,997
77,525
Cash
144,962
162,186
140,670
177,549
Basic Shares
156,362
154,913
158,944
160,626

Annual Financials

Values in thousands2025-06-302024-06-302023-06-302022-06-30
Revenue
$1,219,635
$1,159,060
$1,136,702
$1,105,599
Gross Profit
790,272
769,725
769,815
756,496
EBITDA
216,875
313,136
457,112
413,764
EBIT
106,972
201,425
349,874
312,695
Net Income
73,400
168,105
285,263
272,051
Net Change In Cash
1,219,635
1,159,060
1,136,702
1,105,599
Cost of Revenue
11,360
-14,432
Free Cash Flow
256,550
236,104
216,149
280,364
Cash
162,186
151,791
180,571
172,567
Basic Shares
159,717
160,774
161,855
164,116

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
$0.42
2025-06-30
$0.53
2025-03-31
$0.56